Clinical Trials Browser

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

NCT06606028 2025-12-12

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

Recruiting

250 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01205815 2025-09-19

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Recruiting

3,000 enrolled

Dermatologic

Melanoma

NCT07023822 2025-08-19

WISH, Feasibility of a Factorial Design

Phase NA Active not recruiting

18 enrolled

Breast

Breast Neoplasms

NCT02743910 2025-07-17

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

Active not recruiting

229 enrolled

Breast

Breast Neoplasms

NCT05092009 2025-07-15

IPON-3

Recruiting

600 enrolled

Thoracic

Lung Neoplasms

NCT05577689 2025-06-05

NTTPro

Recruiting

100 enrolled

Genitourinary

Prostatic Neoplasms

NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Terminated

13 enrolled

DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

NCT06323408 2025-03-25

BZKF-AYA

Not yet recruiting

72 enrolled

CNS

Ependymoma, Glioma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal

Clinical Trials

DuTOC

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

WISH, Feasibility of a Factorial Design

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

IPON-3

NTTPro

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

BZKF-AYA